Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Could an effective breast cancer therapy be bad for the heart? | KardiaBand vs. Apple Watch | Noncardiac surgery after TAVR
Monday, July 11, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Could an effective breast cancer therapy be bad for the heart? NIH awards $3.1M to find out

Researchers will examine stress test results, CT images, and blood tests for women who undergo estrogen depletion as a treatment for breast cancer.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Could an effective breast cancer therapy be bad for the heart? NIH awards $3.1M to find out

Share on Twitter Share on Facebook Share on Linkedin
Researchers will examine stress test results, CT images, and blood tests for women who undergo estrogen depletion as a treatment for breast cancer.
READ MORE >

KardiaBand outperforms Apple Watch in diagnosing AFib, but a cardiologist’s perspective is still crucial

The study's authors noted that the ECG acquisition technology in these wearable devices appears to be quite effective. The automated algorithms, however, could still be improved. 

READ MORE >
The KardiaBand device from AliveCor is a more reliable tool for identifying atrial fibrillation (AFib) than the Apple Watch 4, according to a new head-to-head analysis published in JACC: Clinical Electrophysiology.
Share on Twitter Share on Facebook Share on Linkedin

KardiaBand outperforms Apple Watch in diagnosing AFib, but a cardiologist’s perspective is still crucial

Share on Twitter Share on Facebook Share on Linkedin
The KardiaBand device from AliveCor is a more reliable tool for identifying atrial fibrillation (AFib) than the Apple Watch 4, according to a new head-to-head analysis published in JACC: Clinical Electrophysiology.
The study's authors noted that the ECG acquisition technology in these wearable devices appears to be quite effective. The automated algorithms, however, could still be improved. 
READ MORE >

New CAD-RADS 2.0 reporting for coronary CTA offers patient management recommendations

The document includes updated classification to established a framework for stenosis, plaque burden and plaque modifiers, including assessment of CT-FFR or myocardial CT perfusion.

READ MORE >
Examples of new plaque reporting in the CAD-RADS 2.0 document. Left, an example from CAD-RADS 2 / P2 plaque burden with mild coronary stenosis (25-49%). Right, example of a CAD-RADS 5/ P3, with a focal, non-calcified occlusion of the proximal RCA (arrow) and severe amount of plaque (P3). #CADRADS #YesCCT #CTA #CCTA
Share on Twitter Share on Facebook Share on Linkedin

New CAD-RADS 2.0 reporting for coronary CTA offers patient management recommendations

Share on Twitter Share on Facebook Share on Linkedin
Examples of new plaque reporting in the CAD-RADS 2.0 document. Left, an example from CAD-RADS 2 / P2 plaque burden with mild coronary stenosis (25-49%). Right, example of a CAD-RADS 5/ P3, with a focal, non-calcified occlusion of the proximal RCA (arrow) and severe amount of plaque (P3). #CADRADS #YesCCT #CTA #CCTA
The document includes updated classification to established a framework for stenosis, plaque burden and plaque modifiers, including assessment of CT-FFR or myocardial CT perfusion.
READ MORE >

Patients can safely undergo noncardiac surgeries after TAVR without a long delay

However, the study’s authors did find associations between suboptimal TAVR procedures and adverse outcomes.

READ MORE >
While a vast majority of heart transplants in the United States are successful, unplanned hospitalizations after the procedures are still incredibly common. Top 10 reasons for readmission after heart transplant.
Share on Twitter Share on Facebook Share on Linkedin

Patients can safely undergo noncardiac surgeries after TAVR without a long delay

Share on Twitter Share on Facebook Share on Linkedin
While a vast majority of heart transplants in the United States are successful, unplanned hospitalizations after the procedures are still incredibly common. Top 10 reasons for readmission after heart transplant.
However, the study’s authors did find associations between suboptimal TAVR procedures and adverse outcomes.
READ MORE >

Featured Articles

Radiation exposure during structural heart procedures much higher for echocardiographers than cardiologists

The new analysis focused on transcatheter edge-to-edge repair and left atrial appendage occlusion procedures.

READ MORE >
cath_lab.png
Share on Twitter Share on Facebook Share on Linkedin

Radiation exposure during structural heart procedures much higher for echocardiographers than cardiologists

Share on Twitter Share on Facebook Share on Linkedin
cath_lab.png
The new analysis focused on transcatheter edge-to-edge repair and left atrial appendage occlusion procedures.
READ MORE >

Cardiologist’s murder leads to two-day strike among doctors in Turkey

Media coverage of the cardiologist's murder has been banned among Turkish media outlets. 

READ MORE >
Turkish healthcare workers will strike for two days in protest to the murder of cardiologist Ekrem Karakaya and his secretary after the Turkish government banned any news reports about the murders.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist’s murder leads to two-day strike among doctors in Turkey

Share on Twitter Share on Facebook Share on Linkedin
Turkish healthcare workers will strike for two days in protest to the murder of cardiologist Ekrem Karakaya and his secretary after the Turkish government banned any news reports about the murders.
Media coverage of the cardiologist's murder has been banned among Turkish media outlets. 
READ MORE >

U.S. expected to see large rise in cardiomyopathy cases over next decade

“Even if we compensate for the differences in population size, the U.S. is still miles ahead when it comes to total cardiomyopathy cases," explained Walter Gabriel, MPH, an epidemiologist and analyst on the report.

READ MORE >
The projected number of acquired cardiomyopathy cases are expected to greatly outpace the number of new familial cardiomyopathy cases by 2031 in the U.S., driven mainly by poor lifestyles. This is expected to have a big impact on healthcare.
Share on Twitter Share on Facebook Share on Linkedin

U.S. expected to see large rise in cardiomyopathy cases over next decade

Share on Twitter Share on Facebook Share on Linkedin
The projected number of acquired cardiomyopathy cases are expected to greatly outpace the number of new familial cardiomyopathy cases by 2031 in the U.S., driven mainly by poor lifestyles. This is expected to have a big impact on healthcare.
“Even if we compensate for the differences in population size, the U.S. is still miles ahead when it comes to total cardiomyopathy cases," explained Walter Gabriel, MPH, an epidemiologist and analyst on the report.
READ MORE >

New LAA occluder technology and the debate on echo vs. CT image guidance

At TVT 2022, there was debate whether CT imaging is needed for preplanning LAA procedures, and several new devices in development were discussed.

READ MORE >
View of an Amulet left atrial appendage (LAA) occluder on 4D intra-cardiac echo (ICE) from a GE NuVision ICE catheter. Since ICE is operated by the interventionalist, it can be used to reduce the number of people needed to perform an LAA occlusion procedure.  
Share on Twitter Share on Facebook Share on Linkedin

New LAA occluder technology and the debate on echo vs. CT image guidance

Share on Twitter Share on Facebook Share on Linkedin
View of an Amulet left atrial appendage (LAA) occluder on 4D intra-cardiac echo (ICE) from a GE NuVision ICE catheter. Since ICE is operated by the interventionalist, it can be used to reduce the number of people needed to perform an LAA occlusion procedure.  
At TVT 2022, there was debate whether CT imaging is needed for preplanning LAA procedures, and several new devices in development were discussed.
READ MORE >

In Other News

Proposed Medicare Physician Fee Schedule includes payment cuts

The CMS proposal was met with immediate criticism from the American Medical Association. 

READ MORE >
money maze payment reimbursement
Share on Twitter Share on Facebook Share on Linkedin

Proposed Medicare Physician Fee Schedule includes payment cuts

Share on Twitter Share on Facebook Share on Linkedin
money maze payment reimbursement
The CMS proposal was met with immediate criticism from the American Medical Association. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme